Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

MEDIDATA SOLUTIONS INC (MDSO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CEST

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
[email protected]
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
02:43pMEDIDATA : Life Science Leaders Discuss Future of Drug Development at Medidata N..
BU
04/19MEDIDATA SOLUTIONS (NASDAQ : MDSO) reported earnings of $0.40 per share beating ..
AQ
04/19MEDIDATA : 1Q Earnings Snapshot
AQ
04/19MEDIDATA SOLUTIONS, INC. : Results of Operations and Financial Condition, Financ..
AQ
04/19MEDIDATA : Reports First Quarter 2018 Results
BU
04/19MEDIDATA SOLUTIONS INC : Medidata Solutions, Inc. to Host Earnings Call
AC
04/05MEDIDATA : Schedules First Quarter Earnings Conference Call for April 19, 2018
BU
04/04+12% CAGR TO BE ACHIEVED BY CLINICAL : New Research on Clinical Trial Management..
AQ
04/04MEDIDATA : Australia NHMRC Clinical Trials Centre Partners with Medidata to Digi..
BU
03/28MEDIDATA : Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to E..
BU
More news
News from SeekingAlpha
04/19Medidata Solutions' (MDSO) CEO Tarek Sherif on Q1 2018 Results - Earnings Cal.. 
04/19Medidata Solutions beats by $0.05, beats on revenue 
04/18Notable earnings before Thursday?s open 
04/17J&J cost cutting plan may pressure suppliers - Bloomberg 
04/13Cross-Selling Can Drive Meaningful Growth For Medidata Solutions 
Financials ($)
Sales 2018 638 M
EBIT 2018 141 M
Net income 2018 48,3 M
Finance 2018 145 M
Yield 2018 -
P/E ratio 2018 91,66
P/E ratio 2019 64,81
EV / Sales 2018 6,57x
EV / Sales 2019 5,41x
Capitalization 4 332 M
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Technical analysis trends MEDIDATA SOLUTIONS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 80,5 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Rouven Bergmann Chief Financial & Accounting Officer
Julie Iskow Chief Technology Officer
Neil M. Kurtz Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC14.42%4 332
INTERNATIONAL BUSINESS MACHINES CORPORATION-4.93%133 477
TATA CONSULTANCY SERVICES26.44%98 220
ACCENTURE-0.44%98 013
VMWARE, INC.8.56%54 847
AUTOMATIC DATA PROCESSING-0.30%51 792